Literature DB >> 6279645

Albumin stabilizes leukotriene A4.

F A Fitzpatrick, D R Morton, M A Wynalda.   

Abstract

Chemical analysis of intact leukotriene A4 showed that vertebrate albumins prolonged its aqueous half-life. At pH 7.4, leukotriene A4 hydrolyzed by first order reaction kinetics with rate constants inversely proportional to the albumin concentration. The stabilizing effect of albumin varied quantitatively among different species. Certain agents, such as warfarin, that interact with the site I binding region of albumin reversed its stabilizing effect. Sequestration and exposure of leukotriene A4 to a hydrophobic, alkaline microenvironment of albumin would account for the results. The amino acid sequences Lys-Ala-Trp-Ala-Val-Ala-Arg from residues 211-217 of human albumin or Lys-Ala-Trp-Ser-Val-Ala-Arg from residues 210-216 of bovine albumin are compatible with this requirement. The persistence of leukotriene A4 in the presence of albumin confirms and extends our recent observations on its uniform and predictable influence on eicosanoid stability. The significance of this influence is uncertain; however, albumin can no longer be viewed as inert considering its capacity to modify the stability of several, structurally diverse eicosanoids.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279645

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Joint tissues amplify inflammation and alter their invasive behavior via leukotriene B4 in experimental inflammatory arthritis.

Authors:  Mei Chen; Bing K Lam; Andrew D Luster; Simona Zarini; Robert C Murphy; Angela M Bair; Roy J Soberman; David M Lee
Journal:  J Immunol       Date:  2010-09-27       Impact factor: 5.422

2.  Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation.

Authors:  J K Beckman; J C Gay; A R Brash; J N Lukens; J A Oates
Journal:  Lipids       Date:  1985-06       Impact factor: 1.880

3.  Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes.

Authors:  Tanya M Laidlaw; Molly S Kidder; Neil Bhattacharyya; Wei Xing; Shiliang Shen; Ginger L Milne; Mariana C Castells; Heng Chhay; Joshua A Boyce
Journal:  Blood       Date:  2012-01-18       Impact factor: 22.113

4.  Structural insights into human serum albumin-mediated prostaglandin catalysis.

Authors:  Jinsheng Yang; Charles E Petersen; Chung-Eun Ha; Nadhipuram V Bhagavan
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

Review 5.  Metabolic interactions between eicosanoids in blood and vascular cells.

Authors:  M Lagarde; N Gualde; M Rigaud
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

Review 6.  Lysophospholipid acyltransferases and leukotriene biosynthesis: intersection of the Lands cycle and the arachidonate PI cycle.

Authors:  Robert C Murphy; Giancarlo Folco
Journal:  J Lipid Res       Date:  2019-01-03       Impact factor: 5.922

7.  Biosynthesis, isolation, and NMR analysis of leukotriene A epoxides: substrate chirality as a determinant of the cis or trans epoxide configuration.

Authors:  Jing Jin; Yuxiang Zheng; William E Boeglin; Alan R Brash
Journal:  J Lipid Res       Date:  2012-12-13       Impact factor: 5.922

8.  Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy.

Authors:  Ramaprasad Talahalli; Simona Zarini; Nader Sheibani; Robert C Murphy; Rose A Gubitosi-Klug
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-15       Impact factor: 4.799

9.  Leukotriene A4 modulates generation of leukotriene B4 and sulphidopeptide leukotrienes by human neutrophils.

Authors:  R A Hilger; W König
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

10.  Enzymatic synthesis of a bicyclobutane fatty acid by a hemoprotein lipoxygenase fusion protein from the cyanobacterium Anabaena PCC 7120.

Authors:  Claus Schneider; Katrin Niisuke; William E Boeglin; Markus Voehler; Donald F Stec; Ned A Porter; Alan R Brash
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.